Learn about Venetoclax, a promising drug for the treatment of B cell malignancies, including lymphomas and multiple myeloma. This drug specifically targets the anti-apoptotic protein BCL-2. Watch the video below for more information on its administration and success rates in clinical trials, including in combination with other drugs like dexamethasone and bortezomib. Don't miss out on this exciting new development in cancer treatment! HealthTree University.
We have over 500 HealthTree University videos online at HealthTree University! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!
about the author
Cynthia Chmielewski
Cynthia (Cindy) Chmielewski is a professional educator and myeloma advocate. As a former teacher, she now teaches myeloma patients how to advocate for themselves as the Director of HealthTree University. You can follow her on Twitter @myelomateacher
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.